Cic edizioni internazionali
Functional Neurology

Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey

Original Article, 253 - 258
doi: 10.11138/FNeur/2013.28.4.253
Tag this article
Abstract
Enhanced HTML Full text PDF
The aim of this survey was to provide an overview of important issues relating to therapeutic strategies based on botulinum toxin type A injection for the treatment of patients with neurological disorders.
Two hundred and ten physicians from neurology and neurorehabilitation units in Italian hospitals answered a questionnaire exploring some clinical aspects of the use of botulinum toxin type A in patients with spasticity/dystonia. 66% of the physicians treated patients with dystonia, 80% treated adults with spasticity, and 35% treated children with cerebral palsy.
Palpation with no instrumental guidance was the injection technique most commonly used for treating patients with dystonia, spasticity and cerebral palsy; 57% of the physicians evaluated patients instrumentally before toxin injection, while 45% assessed postinjection improvements by instrumental means; 78% of the physicians prescribed (when appropriate) rehabilitation procedures after toxin injection. Our results seem to show that the routine use of botulinum toxin in clinics is far from standardized.

Vol. XXXIII (No. 2) 2018 April/June

  1. Shorter acute care hospital stay, longer stay in post-acute care facilities
    Formisano R., Contrada M., Aloisi M.
    doi: 10.11138/FNeur/2018.33.2.065
  2. Understanding the pathophysiology of hyperglycemia-associated chorea-ballism: a systematic review of positron emission tomography findings
    Gómez Ochoa S. A., Espín Chico B.B.
    doi: 10.11138/FNeur/2018.33.2.067
  3. A review of 500 patients with acute stroke admitted to the University Hospital of Saudi Arabia. Similarities and differences compared with the published literature
    Zafar A.
    doi: 10.11138/FNeur/2018.33.2.073
  4. Direction-specific cortical response immediately after moving tactile stimuli in female humans
    Hiraoka K., Kento Y., Kiya H., Nozaki Y., Hayashi T.
    doi: 10.11138/FNeur/2018.33.2.081
  5. Impact of epilepsy after severe brain injury on safe resumption of driving: two-year follow-up
    Saviola D., De Tanti A., Delsoldato S., Chiari M., Inzaghi M.G., Baldari F.
    doi: 10.11138/FNeur/2018.33.2.091
  6. Epidemiological and clinical characteristics of 492 patients in a vegetative state in 29 Italian rehabilitation units. What about outcome?
    Avesani R., Dambruoso F., Scandola M., Formisano R., De Tanti A., Ferro S., Smania N., Roncari L., Rossato E.
    doi: 10.11138/FNeur/2018.33.2.097
  7. Laterality in Parkinson’s disease may predict motor and visual imagery abilities
    Lo Monaco M.R., Laudisio A., Fusco D., Vetrano D.L., Ricciardi D., Delle Donne V., Proietti F., Zuccalà G., Silveri M.C.
    doi: 10.11138/FNeur/2018.33.2.105
  8. Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study
    Baricich A., Cosenza L., Sandrini G., Paolucci S., Morone G., Santamato A., Cinone N., Peri E., Picelli A., Invernizzi M., Ferriero G.
    doi: 10.11138/FNeur/2018.33.2.113
  9. Musculoskeletal impairment and functional limitations in a patient affected by mutation in the laminin a-5 gene
    Liguori S., de Sire A., Moretti A., Sodano L., Sampaolo S., Gimigliano F., Iolascon G.
    doi: 10.11138/FNeur/2018.33.2.117
Last Viewed articles: la lista degli ultimi x visitati.
  1. Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey
    Smania N., Colosimo C., Bentivoglio A.R., Sandrini G., Picelli A.
    doi: 10.11138/FNeur/2013.28.4.253
credits